日本新薬(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証PRM医薬品4516/E00931-
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2019/10/18日証協無担保0株-100%3,500株-30%2,006株0%
2019/10/18日証協有担保130,232株-85.58%600株-95.14%50,857株-88.33%
2019/10/11日証協無担保247,100株+254.52%5,000株0%0株-100%
2019/10/11日証協有担保903,196株+350.86%12,342株+931.08%435,910株+182%
2019/10/04日証協無担保69,700株+38.84%0株0%852株-93.61%
2019/10/04日証協有担保200,329株+136.34%1,197株-94.89%154,578株-69.57%
2019/09/27日証協無担保50,200株+1519.35%0株0%13,327株+1010.58%
2019/09/27日証協有担保84,764株-77.6%23,430株-82.47%507,897株+64.6%
2019/09/20日証協無担保3,100株-92.25%0株0%1,200株+70.94%
2019/09/20日証協有担保378,423株+26.23%133,645株-43.5%308,560株+27.83%
2019/09/13日証協無担保40,000株0%0株-100%702株+247.52%
2019/09/13日証協有担保299,791株+176.09%236,526株+77.08%241,374株+355.42%
2019/09/06日証協無担保0株-100%1,400株0%202株0%
2019/09/06日証協有担保108,586株-5.17%133,567株+122.71%53,000株-10.21%
2019/08/30日証協無担保1,100株-45%0株0%0株-100%
2019/08/30日証協有担保114,500株+367.35%59,974株-39.62%59,026株+233.48%
2019/08/23日証協無担保2,000株-88.51%0株0%500株+400%
2019/08/23日証協有担保24,500株-81.1%99,320株+367.5%17,700株-88.16%
2019/08/16日証協無担保17,400株-13.86%0株0%100株-1.96%
2019/08/16日証協有担保129,641株-48.78%21,245株+114.75%149,500株+17.35%
2019/08/09日証協無担保20,200株+121.98%0株0%102株-49%
2019/08/09日証協有担保253,085株+97.05%9,893株+13.7%127,402株+274.71%
2019/08/02日証協無担保9,100株0%0株0%200株+9900%
2019/08/02日証協有担保128,438株-37.88%8,701株+2800.33%34,000株-72.65%
2019/07/26日証協無担保0株-100%0株0%2株-99.67%
2019/07/26日証協有担保206,756株+46.77%300株-95.24%124,325株+410.89%
2019/07/19日証協無担保7,900株-88.48%0株0%600株+476.92%
2019/07/19日証協有担保140,873株-72.15%6,300株-34.38%24,335株-76.24%
2019/07/12日証協無担保68,600株+1978.79%0株0%104株0%
2019/07/12日証協有担保505,748株+55.4%9,600株+146.03%102,400株+3.43%
2019/07/05日証協無担保3,300株+94.12%0株0%0株-100%
2019/07/05日証協有担保325,445株+37.06%3,902株-54.9%99,000株+36.36%
2019/06/28日証協無担保1,700株-59.52%0株0%202株-66.45%
2019/06/28日証協有担保237,453株-10.5%8,651株-75%72,600株-31.05%
2019/06/21日証協無担保4,200株0%0株0%602株+50.5%
2019/06/21日証協有担保265,298株+3.09%34,609株+3.49%105,300株+98.68%
2019/06/14日証協無担保0株-100%0株0%400株+31.15%
2019/06/14日証協有担保257,357株+84.23%33,443株+38.02%53,000株+3.74%

※株式分割は考慮していませんのでご注意ください。

Page Top